Resources
Regulatory sandbox for RWE projects explained at a conference by Data MATRIX
The goal of the meeting was to explain the role of the regulatory sandbox for RWE projects and the implications for pharma.
10 December 2021
#news
Data MATRIX has won the Patents Power 2021 contest by Bayer and Skolkovo
The team presented its AI-driven predictive treatment tool with high potential for intellectual property rights protection.
08 December 2021
#news
Data MATRIX becomes the only company in Russia that can officially collect…
The Ministry of Economic Development of Russia announced the participation of Data MATRIX in the regulatory sandbox.
18 October 2021
#news
Data MATRIX and Webiomed became partners in routine clinical research
The Skolkovo Foundation residents Data MATRIX and K-Sky (the developer of the Webiomed predictive analytics platform) signed…
18 October 2021
#news
Data MATRIX is creating a National Biomedical Data Bank, which Russian…
Data MATRIX, which conducts routine clinical practice (RWE) studies based on anonymized data from electronic medical records,…
13 October 2021
#news
Data Matrix is the only company in the field of RWE which has been included…
This was announced by Vadim Merkulov, Deputy General of the FSBI «SCEEMP» at the Ministry of Health of the Russian Federation
29 September 2021
#news
